466 related articles for article (PubMed ID: 12794302)
1. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
Kaplan B; Ratner V; Haas E
J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
[TBL] [Abstract][Full Text] [Related]
2. Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?
Windisch M; Hutter-Paier B; Schreiner E; Wronski R
J Mol Neurosci; 2004; 24(1):155-65. PubMed ID: 15314265
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
[TBL] [Abstract][Full Text] [Related]
4. Synucleins in synaptic plasticity and neurodegenerative disorders.
Clayton DF; George JM
J Neurosci Res; 1999 Oct; 58(1):120-9. PubMed ID: 10491577
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology of synuclein aggregates.
Duda JE; Lee VM; Trojanowski JQ
J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
[TBL] [Abstract][Full Text] [Related]
6. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
Arawaka S; Saito Y; Murayama S; Mori H
Neurology; 1998 Sep; 51(3):887-9. PubMed ID: 9748051
[TBL] [Abstract][Full Text] [Related]
7. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Conway KA; Harper JD; Lansbury PT
Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
[TBL] [Abstract][Full Text] [Related]
8. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
Iwai A
Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology in mice expressing human alpha-synuclein.
van der Putten H; Wiederhold KH; Probst A; Barbieri S; Mistl C; Danner S; Kauffmann S; Hofele K; Spooren WP; Ruegg MA; Lin S; Caroni P; Sommer B; Tolnay M; Bilbe G
J Neurosci; 2000 Aug; 20(16):6021-9. PubMed ID: 10934251
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.
Lee SS; Kim YM; Junn E; Lee G; Park KH; Tanaka M; Ronchetti RD; Quezado MM; Mouradian MM
Neurobiol Aging; 2003 Sep; 24(5):687-96. PubMed ID: 12885576
[TBL] [Abstract][Full Text] [Related]
11. Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins.
El-Agnaf OM; Irvine GB
J Struct Biol; 2000 Jun; 130(2-3):300-9. PubMed ID: 10940234
[TBL] [Abstract][Full Text] [Related]
12. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
Culvenor JG; McLean CA; Cutt S; Campbell BC; Maher F; Jäkälä P; Hartmann T; Beyreuther K; Masters CL; Li QX
Am J Pathol; 1999 Oct; 155(4):1173-81. PubMed ID: 10514400
[TBL] [Abstract][Full Text] [Related]
13. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
Lindersson E; Lundvig D; Petersen C; Madsen P; Nyengaard JR; Højrup P; Moos T; Otzen D; Gai WP; Blumbergs PC; Jensen PH
J Biol Chem; 2005 Feb; 280(7):5703-15. PubMed ID: 15590652
[TBL] [Abstract][Full Text] [Related]
14. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
15. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
[TBL] [Abstract][Full Text] [Related]
16. Neuropathological spectrum of synucleinopathies.
Jellinger KA
Mov Disord; 2003 Sep; 18 Suppl 6():S2-12. PubMed ID: 14502650
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein, Abeta and Alzheimer's disease.
Wirths O; Bayer TA
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
[TBL] [Abstract][Full Text] [Related]
18. Lewy body pathology in Alzheimer's disease.
Kotzbauer PT; Trojanowsk JQ; Lee VM
J Mol Neurosci; 2001 Oct; 17(2):225-32. PubMed ID: 11816795
[TBL] [Abstract][Full Text] [Related]
19. The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.
Hashimoto M; Kawahara K; Bar-On P; Rockenstein E; Crews L; Masliah E
J Mol Neurosci; 2004; 24(3):343-52. PubMed ID: 15655259
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
